BIOMAT Database Logo BIOMAT Database Logo

PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756. 1994

A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Department of Neurology, University of Turku, Finland.

PET studies were carried out on brain dopamine D1 receptors using two new ligands, [11C]SCH 39166 and [11C]NNC 756. METHODS Four normal subjects and eight predominantly unilateral patients with early Parkinson's disease were investigated. Each of them underwent both a PET scan with [11C]SCH 39166 and one with [11C]NNC 756. A dose of about 185 MBq (5 mCi) of these ligands was administered intravenously and a dynamic PET scan with an ECAT 931/08 PET camera was carried out. Ratios between the striatal and cerebellar uptake of these compounds were calculated. RESULTS Both [11C]SCH 39166 and [11C]NNC 756 accumulated in the striatum. There was also some neocortical binding; 75% of the striatal value in the case of [11C]SCH 39166 and 60% with [11C]NNC 756 which displayed higher (p < 0.01) uptake in the striatum than [11C]SCH 39166. There were no significant side-to-side differences in the controls nor in the parkinsonian patients. CONCLUSIONS These results imply that both [11C]SCH 39166 and [11C]NNC 756 can be used in PET studies for the visualization and quantification of dopamine D1 receptors. Since [11C]NNC 756 has a significantly better signal-to-noise ratio in the striatum than [11C]SCH 39166, it seems to offer definite advantages for studies of D1 receptors.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
May 1999, Synapse (New York, N.Y.),
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
December 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
January 1993, Psychopharmacology,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
August 1992, European journal of pharmacology,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
August 1992, European journal of pharmacology,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET.
January 1991, Psychopharmacology,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations.
January 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
October 1995, Psychopharmacology,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood.
January 1992, Psychopharmacology,
A O Laihinen, and J O Rinne, and H M Ruottinen, and K A Någren, and P K Lehikoinen, and V J Oikonen, and U H Ruotsalainen, and U K Rinne
Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man.
May 1995, Psychopharmacology,
Copied contents to your clipboard!